Cargando…

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma

Background: Glioblastoma (GBM) is the most common primary malignant brain cancer in adults, with very limited therapeutic options. It is characterized by a severe immunosuppressive milieu mostly triggered by suppressive CD163(+) tumor-associated macrophages (TAMs). The efficacy of immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahimi Koshkaki, Hassan, Minasi, Simone, Ugolini, Alessio, Trevisi, Gianluca, Napoletano, Chiara, Zizzari, Ilaria G., Gessi, Marco, Giangaspero, Felice, Mangiola, Annunziato, Nuti, Marianna, Buttarelli, Francesca R., Rughetti, Aurelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564919/ https://www.ncbi.nlm.nih.gov/pubmed/32899203 http://dx.doi.org/10.3390/jpm10030112

Ejemplares similares

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
por: Scirocchi, Fabio, et al.
Publicado: (2021)

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
por: Pace, Angelica, et al.
Publicado: (2022)

Current Knowledge about the Peritumoral Microenvironment in Glioblastoma
por: Trevisi, Gianluca, et al.
Publicado: (2023)

MGL Receptor and Immunity: When the Ligand Can Make the Difference
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2015)

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2015)

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells
por: Battisti, Federico, et al.
Publicado: (2017)

Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells
por: Dionisi, Marco, et al.
Publicado: (2018)

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis
por: Scirocchi, Fabio, et al.
Publicado: (2022)

IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137(+)T-cells
por: Ugolini, Alessio, et al.
Publicado: (2020)

Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response
por: Zizzari, Ilaria G, et al.
Publicado: (2013)

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
por: Napoletano, Chiara, et al.
Publicado: (2019)

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

Immune Effects of Trastuzumab
por: Nuti, Marianna, et al.
Publicado: (2011)

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
por: Ceccarelli, Fulvia, et al.
Publicado: (2023)

Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma
por: Angelucci, Cristiana, et al.
Publicado: (2021)

Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
por: Napoletano, Chiara, et al.
Publicado: (2013)

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
por: Pace, Angelica, et al.
Publicado: (2023)

Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
por: Bellati, Filippo, et al.
Publicado: (2011)

Circulating CD137(+) T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients
por: Cirillo, Alessio, et al.
Publicado: (2023)

Improvement of the Collection, Maintenance, and Analysis of Neoplastic Cells from Urine Specimens with the Use of CytoMatrix
por: Minasi, Simone, et al.
Publicado: (2021)

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial
por: ANTONILLI, MORENA, et al.
Publicado: (2016)

Immune effects of CDK4/6 inhibitors in patients with HR(+)/HER2(−) metastatic breast cancer: Relief from immunosuppression is associated with clinical response
por: Scirocchi, Fabio, et al.
Publicado: (2022)

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
por: Botticelli, Andrea, et al.
Publicado: (2021)

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2011)

Circulating CD137(+) T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2022)

Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL)
por: Napoletano, Chiara, et al.
Publicado: (2020)

MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
por: Buttarelli, Francesca Romana, et al.
Publicado: (2022)

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
por: Mezi, Silvia, et al.
Publicado: (2023)

HGG-09. MicroRNAs expression profile in Meningioma 1 (MN1) gene altered astroblastoma
por: Antonelli, Manila, et al.
Publicado: (2022)

Introduction
por: Barbareschi, Mattia, et al.
Publicado: (2022)

The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets
por: Cenciarelli, Carlo, et al.
Publicado: (2017)

CD137(+) T-Cells: Protagonists of the Immunotherapy Revolution
por: Ugolini, Alessio, et al.
Publicado: (2021)

Rheumatoid Factor: A Novel Determiner in Cancer History
por: Ugolini, Alessio, et al.
Publicado: (2021)

Myeloid Cells in Glioblastoma Microenvironment
por: De Leo, Alessandra, et al.
Publicado: (2020)

Intraoperative thermal infrared imaging in neurosurgery: machine learning approaches for advanced segmentation of tumors
por: Cardone, Daniela, et al.
Publicado: (2023)

Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
por: Napoletano, Chiara, et al.
Publicado: (2010)

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
por: Dufrusine, Beatrice, et al.
Publicado: (2023)

Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells
por: D'Alessio, Alessio, et al.
Publicado: (2016)

Usefulness of Brain Positron Emission Tomography with Different Tracers in the Evaluation of Patients with Idiopathic Normal Pressure Hydrocephalous
por: Mattoli, Maria Vittoria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o5m8qpanbrs2gm12rpgf899d00